Switch to:

Stemline Therapeutics Inc (STML) Ownership Data

Short Interest History (%)

This is the historical short interest of Stemline Therapeutics Inc, as measured by the Short Percentage Of Float.

Date Short Interest
January 15, 20163.36
December 31, 20152.82
December 15, 20152.89
November 30, 20153.1
November 13, 20153.4
October 30, 20154.18
October 15, 20153.98
September 30, 20153.98
September 15, 20153.64
August 31, 20153.51
August 14, 20153.24
July 31, 20153
July 15, 20153.15
June 30, 20153.22
June 15, 20153.77
May 29, 20154.13
May 15, 20155.32
April 30, 20154.11
April 15, 20157.53
March 31, 20157.24
March 13, 20157.08
February 27, 20157.67
February 13, 20158.84
January 30, 20158.78
January 15, 20158.15
December 31, 20149.85
December 15, 201411.44
November 28, 201411.63
November 14, 201411.48
October 31, 201410.61
October 15, 201410.59
September 30, 20149.24
September 15, 20149.8
August 29, 20149.33
August 15, 20149.11
July 31, 20149.01
July 15, 20148.82
June 30, 20148.55
June 13, 20149.41
May 30, 20149.95
May 15, 20149.53
April 30, 20148.94
April 15, 201413.28
March 31, 201412.98
March 14, 201412.99
February 28, 201411.85
February 14, 201412.59
January 31, 20149.44
January 15, 20147.47
December 31, 20137.4
December 13, 20137.97
November 29, 20138.32
November 15, 20137.77
October 31, 20137.71
October 15, 20137.77
September 30, 20138.65
September 13, 201310.81
August 30, 201312.98
August 15, 201314.74
July 31, 201315.5
July 15, 201316.78
June 28, 20135.43
June 14, 20133.81
May 31, 20131.41
May 15, 20131.9
April 30, 20132.12
April 15, 20132.36
March 28, 20132.33
March 15, 20132.15
February 28, 20131.92
February 15, 20131.68
January 31, 20130.78

Institutional Ownership History (%)

This the Institutional Ownership History of Stemline Therapeutics IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
December 31, 201574.9
September 30, 201574.26
June 30, 201563.52
March 31, 201565.57
December 31, 201460.31
September 30, 201454.92
June 30, 201464.91
March 31, 201465.19
December 31, 201364.71
September 30, 201360.18
June 30, 201364.12
March 31, 201338.95

Insider ownership (%)

This is the historical insider ownership of Stemline Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
December 31, 201512.34
November 30, 201513.33
October 31, 201513.42
September 30, 201513.42
August 31, 201513.47
July 31, 201513.47
June 30, 201513.47
May 31, 201513.22
April 30, 201513.28
March 31, 201513.1
February 28, 201516.64
January 31, 201516.69
December 31, 201416.28
November 30, 201416.72
October 31, 201416.84
September 30, 201416.84
August 31, 201416.84
July 31, 201416.79
June 30, 201416.79
May 31, 201416.79

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Ivan BergsteinCEO, 10% Owner1,676,8269.32%2015-12-31
Mr. Kenneth HobermanCOO212,5621.18%2016-01-07
Dr. Eric K. Rowinsky,M.D.Chief Medical Officer143,6880.8%2015-04-27
Alan S. FormanN/A48,1400.27%2015-06-23
Stephen P. HallN/A40,0000.22%2013-06-19
Mr. David G. GioncoChief Accounting Officer35,2440.2%2016-01-19
Mr. J. Kevin BuchiDirector23,7720.13%2015-06-23
Mr. Kenneth J. ZuerblisDirector21,9630.12%2015-06-23
Eric L. DobmeierN/A17,9630.1%2015-06-23
Ron BentsurDirector17,2850.1%2015-06-23

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Fidelity Management and Research Company   Premium Plus1,861,9142015-09-3012.52N/A19,867
Franklin Advisers Inc   Premium Plus1,558,5302015-09-3010.480.0116,630
Fidelity® Select Biotechnology Portfolio1,513,2992015-11-308.410.0812,470
TimesSquare Capital Management, LLC   Premium Plus1,195,2802015-09-308.040.0812,754
Franklin Biotechnology Discovery Fund1,002,9302015-10-315.580.338,916
Eventide Asset Management, LLC   Premium Plus735,0002015-09-304.940.437,842
Farallon Capital Management, L.L.C.   Premium Plus676,1622015-09-304.550.097,215
Franklin Biotechnology Discovery Fund606,4002015-12-313.370.233,826
Great Point Partners LLC   Premium Plus475,2002015-09-303.201.785,070
Vanguard Group Inc   Premium Plus458,3362015-09-303.08N/A4,890

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK